According to the Atlanta-based Centers for Disease Control and Prevention, the type of flu vaccine and number of doses needed ...

The shot, made by Moderna, will be available for this year's upcoming flu season.

The Food and Drug Administration has approved the first influenza vaccine built on messenger RNA technology, the same platform that powered the leading COVID-19 shots. The vaccine, branded mFLUSIVA, ...

The FDA’s approval is welcome news, and will hopefully open the door to much faster production of an effective vaccine to counter any future flu pandemic.

FLUSIVA becomes Moderna's fifth approved product globally and fourth FDA-approved product Company expects supply to be available in select retailers in the coming weeks CAMBRIDGE, MA / ACCESS Newswire ...

A new mRNA flu vaccine showed a 27% reduction in flu cases in a clinical trial, but its path to FDA approval faced an early regulatory setback.

On August 5, 2026, Moderna announced that the U.S. Food and Drug Administration (FDA) approved mFLUSIVA® (mRNA-1010), a seasonal influenza vaccine ...

Add Yahoo as a preferred source to see more of our stories on Google. The U.S. Food and Drug Administration has approved a new seasonal flu vaccine from Moderna that uses mRNA technology, the ...

The Food and Drug Administration has approved the first messenger RNA-based vaccine for seasonal flu, after rejecting it earlier this year. Moderna’s new seasonal flu vaccine using mRNA technology for ...

Add Yahoo as a preferred source to see more of our stories on Google. The FDA on Aug. 5, 2026 approved a new mRNA-based flu vaccine. (Melissa Phillip/AP) After months of regulatory questioning, the ...

A first-of-its-kind flu shot is one step closer to being available to the public after a Food and Drug Administration (FDA) advisory panel voted Thursday to recommend Moderna’s mRNA-based vaccine for ...

The U.S. Food and Drug Administration has approved a new seasonal flu vaccine from Moderna that uses mRNA technology, the drugmaker announced.